These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 28320199

  • 1. Comparison of imaging using 11C-ITMM and 18F-FDG for the detection of cerebellar ataxia.
    Ishibashi K, Miura Y, Toyohara J, Ishii K, Ishiwata K.
    J Neurol Sci; 2017 Apr 15; 375():97-102. PubMed ID: 28320199
    [Abstract] [Full Text] [Related]

  • 2. Relationship between type 1 metabotropic glutamate receptors and cerebellar ataxia.
    Ishibashi K, Miura Y, Ishikawa K, Zhang MR, Toyohara J, Ishiwata K, Ishii K.
    J Neurol; 2016 Nov 15; 263(11):2179-2187. PubMed ID: 27502082
    [Abstract] [Full Text] [Related]

  • 3. Decreased metabotropic glutamate receptor type 1 availability in a patient with spinocerebellar ataxia type 6: A (11)C-ITMM PET study.
    Ishibashi K, Miura Y, Ishikawa K, Ishii K, Ishiwata K.
    J Neurol Sci; 2015 Aug 15; 355(1-2):202-5. PubMed ID: 26055313
    [Abstract] [Full Text] [Related]

  • 4. Initial human PET studies of metabotropic glutamate receptor type 1 ligand 11C-ITMM.
    Toyohara J, Sakata M, Oda K, Ishii K, Ito K, Hiura M, Fujinaga M, Yamasaki T, Zhang MR, Ishiwata K.
    J Nucl Med; 2013 Aug 15; 54(8):1302-7. PubMed ID: 23804329
    [Abstract] [Full Text] [Related]

  • 5. Unchanged type 1 metabotropic glutamate receptor availability in patients with Alzheimer's disease: A study using 11C-ITMM positron emission tomography.
    Ishibashi K, Miura Y, Toyohara J, Ishiwata K, Ishii K.
    Neuroimage Clin; 2019 Aug 15; 22():101783. PubMed ID: 30909027
    [Abstract] [Full Text] [Related]

  • 6. Preclinical and the first clinical studies on [11C]ITMM for mapping metabotropic glutamate receptor subtype 1 by positron emission tomography.
    Toyohara J, Sakata M, Fujinaga M, Yamasaki T, Oda K, Ishii K, Zhang MR, Moriguchi Jeckel CM, Ishiwata K.
    Nucl Med Biol; 2013 Feb 15; 40(2):214-20. PubMed ID: 23265669
    [Abstract] [Full Text] [Related]

  • 7. Different subregional metabolism patterns in patients with cerebellar ataxia by 18F-fluorodeoxyglucose positron emission tomography.
    Oh M, Kim JS, Oh JS, Lee CS, Chung SJ.
    PLoS One; 2017 Feb 15; 12(3):e0173275. PubMed ID: 28319124
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain.
    Fujinaga M, Yamasaki T, Yui J, Hatori A, Xie L, Kawamura K, Asagawa C, Kumata K, Yoshida Y, Ogawa M, Nengaki N, Fukumura T, Zhang MR.
    J Med Chem; 2012 Mar 08; 55(5):2342-52. PubMed ID: 22316010
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Brain 11 C-ITMM PET to longitudinally assess type 1 metabotropic glutamate receptor availability in Alzheimer's disease.
    Ishibashi K, Miura Y, Wagatsuma K, Kameyama M, Ishii K.
    J Neuroimaging; 2021 Sep 08; 31(5):864-868. PubMed ID: 34143915
    [Abstract] [Full Text] [Related]

  • 11.
    Leung K.
    ; 2004 Sep 08. PubMed ID: 23638488
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improved Visualization and Specific Binding for Metabotropic Glutamate Receptor Subtype 1 (mGluR1) Using [11C]ITMM with Ultra-High Specific Activity in Small-Animal PET.
    Yamasaki T, Fujinaga M, Yui J, Wakizaka H, Ohya T, Nengaki N, Ogawa M, Ikoma Y, Hatori A, Xie L, Kawamura K, Zhang MR.
    PLoS One; 2015 Sep 08; 10(6):e0130006. PubMed ID: 26076143
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
    Masangkay N, Basu S, Moghbel M, Kwee T, Alavi A.
    Nucl Med Commun; 2014 Oct 08; 35(10):1038-46. PubMed ID: 25023997
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.